Ali S - Search Results

1

Endocrine-responsive breast cancer and strategies for combating resistance.

Ali S, Coombes RC. Ali S, et al. Nat Rev Cancer. 2002 Feb;2(2):101-12. doi: 10.1038/nrc721. Nat Rev Cancer. 2002. PMID: 12635173 Review.

2

Presence of exon 5-deleted oestrogen receptor in human breast cancer: functional analysis and clinical significance.

Desai AJ, Luqmani YA, Walters JE, Coope RC, Dagg B, Gomm JJ, Pace PE, Rees CN, Thirunavukkarasu V, Shousha S, Groome NP, Coombes R, Ali S. Desai AJ, et al. Among authors: ali s. Br J Cancer. 1997;75(8):1173-84. doi: 10.1038/bjc.1997.202. Br J Cancer. 1997. PMID: 9099967 Free PMC article.

3

An important role for BRCA1 in breast cancer progression is indicated by its loss in a large proportion of non-familial breast cancers.

Taylor J, Lymboura M, Pace PE, A'hern RP, Desai AJ, Shousha S, Coombes RC, Ali S. Taylor J, et al. Among authors: ali s. Int J Cancer. 1998 Aug 21;79(4):334-42. doi: 10.1002/(sici)1097-0215(19980821)79:4<334::aid-ijc5>3.0.co;2-w. Int J Cancer. 1998. PMID: 9699523

4

Analysis of estrogen-responsive finger protein expression in benign and malignant human breast.

Thomson SD, Ali S, Pickles L, Taylor J, Pace PE, Lymboura M, Shousha S, Coombes RC. Thomson SD, et al. Among authors: ali s. Int J Cancer. 2001 Jan 15;91(2):152-8. doi: 10.1002/1097-0215(200002)9999:9999<::aid-ijc1032>3.0.co;2-y. Int J Cancer. 2001. PMID: 11146438

5

Retroviral infection of the FGF2 gene into MCF-7 cells induces branching morphogenesis, retards cell growth and suppresses tumorigenicity in nude mice.

Liu D, Buluwela L, Ali S, Thomson S, Gomm JJ, Coombes RC. Liu D, et al. Among authors: ali s. Eur J Cancer. 2001 Jan;37(2):268-80. doi: 10.1016/s0959-8049(00)00392-0. Eur J Cancer. 2001. PMID: 11166156

6

Trichostatin A is a histone deacetylase inhibitor with potent antitumor activity against breast cancer in vivo.

Vigushin DM, Ali S, Pace PE, Mirsaidi N, Ito K, Adcock I, Coombes RC. Vigushin DM, et al. Among authors: ali s. Clin Cancer Res. 2001 Apr;7(4):971-6. Clin Cancer Res. 2001. PMID: 11309348

7

Phosphorylation of human estrogen receptor alpha at serine 118 by two distinct signal transduction pathways revealed by phosphorylation-specific antisera.

Chen D, Washbrook E, Sarwar N, Bates GJ, Pace PE, Thirunuvakkarasu V, Taylor J, Epstein RJ, Fuller-Pace FV, Egly JM, Coombes RC, Ali S. Chen D, et al. Among authors: ali s. Oncogene. 2002 Jul 25;21(32):4921-31. doi: 10.1038/sj.onc.1205420. Oncogene. 2002. PMID: 12118371

8

Molecular changes associated with the acquisition of oestrogen hypersensitivity in MCF-7 breast cancer cells on long-term oestrogen deprivation.

Chan CM, Martin LA, Johnston SR, Ali S, Dowsett M. Chan CM, et al. Among authors: ali s. J Steroid Biochem Mol Biol. 2002 Aug;81(4-5):333-41. doi: 10.1016/s0960-0760(02)00074-2. J Steroid Biochem Mol Biol. 2002. PMID: 12361723

9

Chemokines and breast cancer: a gateway to revolutionary targeted cancer treatments?

Dowsland MH, Harvey JR, Lennard TW, Kirby JA, Ali S. Dowsland MH, et al. Among authors: ali s. Curr Med Chem. 2003 Apr;10(7):579-92. doi: 10.2174/0929867033457944. Curr Med Chem. 2003. PMID: 12678790 Review.

10

Enhanced estrogen receptor (ER) alpha, ERBB2, and MAPK signal transduction pathways operate during the adaptation of MCF-7 cells to long term estrogen deprivation.

Martin LA, Farmer I, Johnston SR, Ali S, Marshall C, Dowsett M. Martin LA, et al. Among authors: ali s. J Biol Chem. 2003 Aug 15;278(33):30458-68. doi: 10.1074/jbc.M305226200. Epub 2003 May 29. J Biol Chem. 2003. PMID: 12775708

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results